Back to Agenda
Precision Medicine and Personalised Healthcare
Session Chair(s)
Marisa Papaluca-Amati, MD
Marisa Papaluca-Amati, Scientific Committees Regulatory Science Strategy, Europe
European Medicines Agency, Netherlands
Disease modifying therapies allow to look at the trajectory of disease combining in silico and real world clinical data. This session will review progress towards prevention and personalised medicine combining biological plausible advances in scientific methods and their application within healthcare systems.
Speaker(s)
Panel Discussion
Elmar Nimmesgern
European Commission, Belgium
Innovative and Personalised Medicine Unit
Panel Discussion
Virginia Acha, PhD, MSc
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Panel Discussion
Bettina Ryll
MPNE, Vision Zero Cancer, Sweden
Member of the First EU Cancer Mission Board
Panel Discussion
Donald Singer, MD, FRCP
EACPT, United Kingdom
Executive Committee
Have an account?